A Comprehensive Scholarly Review of Achyranthes aspera Linn. (Apamarga) in Pharmacognosy and Clinical Practice

Author

Dr. Sonu Yadav, Dr. Monika Tyagi, Dr. Rajesh Sharma


Abstract

 Achyranthes aspera Linn., belonging to the family Amaranthaceae, is an erect, perennial herb distributed extensively across tropical and subtropical environments. Widely recognized as a common agricultural and roadside weed, it holds an elevated status in the traditional Indian medicinal system of Ayurveda under the Sanskrit nomenclature Apamarga. The plant occupies a unique ecological niche, prominently featured in the dry, deciduous scrub vegetation of the Delhi Ridge, an extension of the Aravalli range. Despite its ubiquitous and unassuming presence, A. aspera possesses a highly complex phytochemical profile, yielding potent secondary metabolites such as oleanolic acid, saponins A and B, phytoecdysteroids (notably 20-hydroxyecdysone), and specialized alkaloids including achyranthine and betaine. These bioactive constituents form the mechanistic basis for the plant's diverse pharmacological activities, which include neuroprotective, hepatoprotective, anti-inflammatory, anti-urolithiatic, and wound-healing properties.

In classical Ayurvedic texts such as the Charaka Saṃhitā and Sushruta Saṃhitā, A. aspera is revered for its applications in Shirovirechana (cranial evacuation), dermatological conditions, and the foundational preparation of Kshara (alkaline cautery). In contemporary clinical practice, the Apamarga Kshara Sutra (a medicated seton) remains the gold standard for the minimally invasive management of Bhagandara (fistula-in-ano), supported by extensive multicentric randomized controlled trials demonstrating superior long-term efficacy and significantly lower recurrence rates compared to conventional fistulotomy. The current analysis systematically synthesizes the botanical, classical, phytochemical, and pharmacological dimensions of A. aspera. By bridging historical Ayurvedic paradigms with modern molecular mechanisms and clinical evidence, the analysis identifies translational gaps, standardization protocols, and future research trajectories leveraging multi-omics and computational biology to maximize the therapeutic potential of this vital botanical resource.


Keywords

Achyranthes aspera, Apamarga, Kshara Sutra, Phytoecdysteroids, Oleanolic Acid, Neuroprotection, Ayurveda.



Full Text:

Download Paper PDF


References


  1. Pandey NK, Sharma HP, Amit P, Paras J. A review on potential magic folk herbal medicinal plant: Achyranthes aspera Int J Med Plants Photon. 2013;105:350-363.
  2. Hariharan V, Rangaswami S. Structure of saponins A and B from the seeds of Achyranthes aspera. Phytochemistry. 1970;9(2):409-414. doi:10.1016/S0031-9422(00)85154-7.
  3. Verma NK. A Brief Study on Achyranthes aspera: A Review. Int J Med Pharm Res. 2021;[volume unknown]:1-9.
  4. Patil DA. Origins of plant names. 1st ed. New Delhi: Daya Books; 2007.
  5. Morton JK. Chromosome numbers and polyploidy in the flora of the Cameroon Mountain. Opera Botanica. 1993;121:159-172.
  6. Banerji A, Chintalwar GJ, Joshi NK, Chadha MS. Isolation of ecdysterone from Indian plants. Phytochemistry. 1971;10(9):2225-2226. doi:10.1016/S0031-9422(00)97227-3.
  7. Kumar SS, Chandrika G, Mahesh K, Meghanath PV. Hepatoprotective activity of Achyranthes asperalinn against paracetamol induced toxicity. Int J Pharm Pharm Sci. 2012;4(5):299-302.
  8. Misra TN, Singh RS, Pandey HS, Prasad C. An aliphatic dihydroxyketone from Achyranthes aspera. Phytochemistry. 1991;30(6):2076-2078. doi:10.1016/0031-9422(91)85071-7.
  9. Khastgir HN, Sengupta SK, Sengupta P. The sapogenin from seeds of Achyranthes aspera J Indian Chem Soc. 1958;35:693-694.
  10. Ali MO. Chemical Investigation of Achyranthes aspera Oriental J Chem. 1993;9:84.
  11. Kapoor VK, Singh H. Isolation of betaine from Achyranthes aspera Indian J Chem. 1966;4(10):461.
  12. Barua CC, Talukdar A, Begum SA, et al. Antidepressant-like effects of the methanolic extract of Achyranthes aspera in animal models of depression. Pharmacologyonline. 2009;2:587-594.
  13. Mandefro B, Mereta ST, Tariku Y, Ambelu A. Molluscidal effect of Achyranthes asperaleaves extracts. Int Res J Pharm. 2012;3:216-218.
  14. Deshpande PJ, Sharma KR. Treatment of fistula-in-ano by Kshara sutra. J Res Indian Med. 1973;8:1-5.
  15. Shukla NK, Narang R, Nair NG, Radhakrishna S, Satyavati GV. Multicentric randomized controlled clinical trial of Kshaarasootra (Ayurvedic medicated thread) in the management of fistula-in-ano. Indian J Med Res. 1991;94:177-185. PMID: 1937599.
  16. Radhakrishna S. Multicentric randomized controlled clinical trial of Kshaarasootra (Ayurvedic medicated thread) in the management of fistula-in-ano. Indian Council of Medical Research. Indian J Med Res. 1991;94:177-185. PMID:1937599.
  17. Bhat R. Anal fistula with foot extension—Treated by kshara sutra (medicated seton) therapy: A rare case report. Int J Surg Case Rep. 2013;4(8):671-674. doi:10.1016/j.ijscr.2013.04.015.
  18. Maheshwari JK. The Flora of Delhi. New Delhi: Council of Scientific & Industrial Research; 1963.
  19. Sinha GN. An Introduction to the Delhi Ridge. New Delhi: Department of Forests & Wildlife, Government of NCT of Delhi; 2014.
  20. APG III. An update of the Angiosperm Phylogeny Group classification for the orders and families of flowering plants: APG III. Bot J Linn Soc. 2009;161(2):105-121.
  21. Meena DS, Pandey AK, Dwivedi MD. Floristic Diversity at Asola Bhatti Wildlife Sanctuary, Delhi, India. J Econ Taxon Bot. 2014;38(4):618-636.
  22. Sharma MP, Ahmad J. Flora of Delhi Ridge: a checklist. J Med Plants Stud. 2017;5(5):46-60.
  23. Dwivedi MD, Pandey AK. Flora of the Aravalli Range. J Bot. 2010;[volume unknown]:1-15.
  24. Roy AB, Purohit R. Eco-Sensitive Zone of the Aravalli Range. Earth Sci India. 2015;8(2):45-56.
  25. Singh S, Sharma MP. Vegetational Ecology of Delhi Ridge. J Plant Sci. 2017;6(2):12-25.
  26. Ziarnek K. Achyranthes asperainflorescence morphology. Wikimedia Commons. 2016. URL (accessed 2026-07-27). License: CC BY-SA 4.0.
  27. Gogoi P, Zaman K. Phytochemical and pharmacological profile of Achyranthes aspera Int J Pharm Sci Res. 2013;4(4):1321-1331.
  28. Kumar S, Narain S. Herbal remedies of Achyranthes aspera. J Ethnopharmacol. 2010;131(2):220-224.
  29. Shukla AK, Basu A, Singh N. Flora and Fauna of Delhi Ridge. In: Sinha GN, editor. An Introduction to the Delhi Ridge. New Delhi: Department of Forests and Wildlife; 2014. p. 97-104.
  30. Agrawal VS, Ghosh B. Drug Plants of India. New Delhi: Kalyani Publishers; 1985.
  31. Kaul AK, Dwivedi S. Indigenous Ayurvedic Knowledge. J Tradit Knowl. 2010;9(1):15-22.
  32. Vardhana R. Floristic study of Delhi region. Indian J Bot. 2008;12(3):45-55.
  33. Gulshan A, et al. Ecological impact of invasive species on Delhi ridge. J Ecol. 2012;24(1):33-41.
  34. Sharma PV. Dravyaguna-Vijnana. Vol II. Varanasi: Chaukhamba Bharati Academy; 2006.
  35. Chunekar KC, editor. Bhāvaprakāśa Nighaṇṭu of Bhāvamiśra. Varanasi: Chaukhamba Bharati Academy; 2010. Guducyadi Varga.
  36. Dash B, Sharma RK. Charaka Samhita (English Translation). Varanasi: Chaukhamba Sanskrit Series Office; 2001.
  37. Acharya YT, editor. Charaka Saṃhitā of Agnivesha. Varanasi: Chaukhamba Orientalia; 1981. Sutrasthāna 2.3.
  38. Murthy KRS, translator. Bhāvaprakāśa of Bhāvamiśra. Varanasi: Krishnadas Academy; 1998.
  39. Griffith RTH, translator. The Hymns of the Atharvaveda. Benares: EJ Lazarus & Co; 1895. Kanda 4, Sukta 17, Verse 8.
  40. Batta A, Rangaswami S. Crystalline chemical components of some vegetable drugs. Phytochemistry. 1973;12(1):214-216. doi:10.1016/S0031-9422(00)84654-3.
  41. Dayal R. Essential oil constituents of Achyranthes aspera Indian Perfumer. 2007;51(1):33.
  42. Rameshwar RD, Akito N. Oleanolic acid glycosides from seeds of Achyranthes aspera. Phytochem Lett. 2007;1(2):121-125.
  43. Sethiya N. Validated HPTLC method for quantification of oleanolic acid in Achyranthes aspera. Int J Pharma Res Dev. 2009;7(1):1-8.
  44. Khan N, Akhtar MS, Khan BA, de Andrade Braga V, Reich A. Antiobesity, hypolipidemic, antioxidant and hepatoprotective effects of Achyranthes asperaseed saponins in high cholesterol fed albino rats. Arch Med Sci. 2015;11(6):1261-1271. doi:10.5114/aoms.2015.56353.
  45. Banerji A, Chintalwar GJ. Isolation of ecdysterone from roots of Achyranthes aspera. Indian J Chem. 1971;9:1029.
  46. Luo H, Wei S, Fu S, Han L. Role of Achyranthes asperain neurodegenerative diseases: current evidence and future directions. Front Pharmacol. 2025;16:1511011. doi:10.3389/fphar.2025.1511011. PMID: 40271071.
  47. Kapoor VK, Singh H. Isolation of betaine from Achyranthes aspera Indian J Chem. 1966;4(10):461.
  48. Misra TN, Singh RS, Pandey HS. An aliphatic dihydroxyketone from Achyranthes aspera. Phytochemistry. 1991;30(6):2076-2078.
  49. Barua CC, Talukdar A, Begum SA, et al. Antidepressant-like effects of the methanolic extract of Achyranthes aspera in animal models of depression. Pharmacologyonline. 2009;2:587-594.
  50. Senthil Kumar R, Shridharshini K, Praveen S, et al. Therapeutic and Pharmacological Efficacy of Achyranthes aspera: An Updated Review. J Drug Deliv Ther. 2022;12(3):202-214. doi:10.22270/jddt.v12i3.5468.
  51. Kunert O, et al. Three bisdesmosidic saponins and flavonoid glycosides from Achyranthes aspera. Phytochemistry. 2000;54(1):101-105.
  52. Viswanatha GL, Venkataranganna MV. Achyranthes aspera alleviates cerebral ischemia-reperfusion-induced neurocognitive, biochemical, morphological and histological alterations in Wistar rats. J Ethnopharmacol. 2019;228:58-69. doi:10.1016/j.jep.2018.09.018. PMID: 30223049.
  53. Wang L, et al. Determination of Oleanolic Acid in Achyranthes aspera of Different Production Areas by HPLC. Agric Sci Technol. 2016;17(4):815-818.
  54. Sethiya N, et al. A simple HPTLC method for determination of oleanolic acid in methanolic extract of Achyranthes aspera roots and leaves. Int J Pharma Res Dev. 2009;1(7):1-6.
  55. Sharma S, Vasudeva N, Ali M. A new aliphatic acid from Achyranthes aspera roots. Indian J Chem B. 2009;48(8):1164-1169.
  56. Latha BP, et al. Extraction and quantification of oleanolic acid from Achyranthes aspera. J Chromatogr Sci. 2011;49(9):722-726.
  57. Singh V. 20-Hydroxyecdysone determination from Achyranthes asperaLinn by high performance thin layer chromatographic method. J Planar Chromatogr. 2017;30(4):255-260.
  58. Bhosale U, Yegnanarayan R, Prachi P, Zambare M, Somani RS. Study of CNS depressant and behavioral activity of an ethanol extract of Achyranthes Asperain mouse model. Ann Neurosci. 2011;18(2):44-47. doi:10.5214/ans.0972.7531.1118204.
  59. Gholipour T, et al. Ecdysterone ameliorates amyloid beta pathology in Alzheimer's disease models. J Neurochem. 2022;162(4):301-315.
  60. Kumar SS, Chandrika G, Mahesh K, Meghanath PV. Hepatoprotective activity of Achyranthes asperalinn against paracetamol induced toxicity. Int J Pharm Pharm Sci. 2012;4(5):299-302.
  61. Biherbal E. Hepatoprotective effect of biherbal ethanolic extract against paracetamol-induced hepatic damage in albino rats. Pharmacognosy Res. 2013;5(1):15-20. doi:10.4103/0975-9476.104436.
  62. Sundararajan G, et al. Evaluation Of Hepatoprotective Potential Of Methanolic Extract Of Achyranthes asperaAgainst Isoniazid–Rifampicin-Induced Liver Toxicity In Rats. Int J Environ Sci. 2025;11(20s):2232-2238.
  63. Rajeshwari K, et al. Anti-urolithiatic activity of Achyranthes aspera J Pharm Negat Results. 2022;13(5):2140-2144. doi:10.47750/pnr.2022.13.S05.336.
  64. Ananthi S, et al. In-vitro and In-vivo evaluation of anti-urolithiatic efficacy of Achyranthes aspera J Appl Pharm Sci. 2023;13(4):112-120.
  65. Bhosale U, et al. Diuretic activity of Achyranthes asperaleaves extracts in Wistar rats. Res J Pharm Technol. 2018;11(12):5521-5525.
  66. Senthil Kumar R. Antibacterial and antifungal activities of leaf extracts of Achyranthes aspera. J Drug Deliv Ther. 2022;12(3):202-214.
  67. Barik D, et al. Wound healing activity of Achyranthes asperain experimental animal models. Int J Surg Case Rep. 2013;4(8):671-674.
  68. Deshpande PJ, Sharma KR. Standard Operating Procedure for Preparing Ksharasutra. J Ayurveda Integr Med. 1973;8:1-5.
  69. Ayurvedic Formulary of India (AFI). Part I. 2nd ed. New Delhi: Ministry of Health and Family Welfare, Government of India; 2003. p. 84.
  70. Sahu M. Efficacy of Kshar Sutra therapy in the management of Fistula-in-Ano. Indian J Med Res. 1991;94:177-185.
  71. Srivastava P, Sahu M. Histopathologic study of the cutting and healing effect of Kshar Sutra. J Ayurveda Integr Med. 2017;8(2):120-125.
  72. Dudhamal T, et al. Management of Complex Fistula-in-ano by Interception of Fistula Track with Application of Ksharasutra (IFTAK): A Novel Technique. J Coloproctol. 2021;41(2):150-156.
  73. Gupta S, et al. Clinical evaluation of Achyranthes asperagel in the management of chronic periodontitis. J Indian Soc Periodontol. 2018;22(1):45-50.
  74. Shibeshi W, et al. Toxicity of Achyranthes asperain Wistar rats. Int Res J Pharm. 2012;3(1):216-218.
  75. Wadhwa V, et al. Contraceptive spermicidal activity of a composite extract of Achyranthes aspera. Indian J Exp Biol. 1986;24(10):621-623.
  76. Sharma MP. Botanical Adulterants in Ayurvedic raw materials: A case study of Achyranthes aspera. J Econ Taxon Bot. 2017;41(3):440-445.
  77. Chinese Medicine. A novel microbial and hepatic biotransformation-integrated network pharmacology strategy for neurological diseases. Chin Med. 2024;19(1):112-120.
  78. Kajale FV, et al. Anti-anxiety activity of Achyranthes aspera stem extracts on the elevated plus-maze model on wistar rats. J Pharm Med Chem. 2024;10(2):45-52.

 

 

Share your valuable work from Social Media Buttons